Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series
- Supplementary File 1:
ZIP-Document (ZIP, 1587 KiB)
Heidepriem, J.; Dahlke, C.; Kobbe, R.; Santer, R.; Koch, T.; Fathi, A.; Seco, B.M.S.; Ly, M.L.; Schmiedel, S.; Schwinge, D.; Serna, S.; Sellrie, K.; Reichardt, N.-C.; Seeberger, P.H.; Addo, M.M.; Loeffler, F.F.; on behalf of the ID-UKE COVID-19 Study Group. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series. Pathogens 2021, 10, 438. https://doi.org/10.3390/pathogens10040438
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco BMS, Ly ML, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt N-C, Seeberger PH, Addo MM, Loeffler FF, on behalf of the ID-UKE COVID-19 Study Group. Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series. Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438
Chicago/Turabian StyleHeidepriem, Jasmin, Christine Dahlke, Robin Kobbe, René Santer, Till Koch, Anahita Fathi, Bruna M.S. Seco, My L. Ly, Stefan Schmiedel, Dorothee Schwinge, Sonia Serna, Katrin Sellrie, Niels-Christian Reichardt, Peter H. Seeberger, Marylyn M. Addo, Felix F. Loeffler, and on behalf of the ID-UKE COVID-19 Study Group. 2021. "Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series" Pathogens 10, no. 4: 438. https://doi.org/10.3390/pathogens10040438